Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of Antimicrobial Peptides in Preparation of Drugs for Treating Lung Cancer

A technology for therapeutic drugs and antibacterial peptides, used in drug combinations, anti-tumor drugs, pharmaceutical formulations, etc., to achieve the effects of small molecular weight, improved therapeutic effect, hemolytic activity and low cytotoxicity

Active Publication Date: 2022-06-14
THE SECOND HOSPITAL AFFILIATED TO SUZHOU UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

CN105061573A discloses Yaofly natural anti-inflammatory polypeptide cecropin-TY1 and its application in the preparation of anti-inflammatory drugs. Whether the antibacterial peptide has lung cancer inhibitory effect is still unknown
However, because surgery is prone to relapse and postoperative complications, the side effects of radiotherapy and chemotherapy drugs are large and drug resistance is likely to occur, and molecular targeted drugs will also produce different degrees of acquired drug resistance, which limits the current lung cancer treatment to a certain extent. Application of therapeutic means in clinical treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Antimicrobial Peptides in Preparation of Drugs for Treating Lung Cancer
  • Application of Antimicrobial Peptides in Preparation of Drugs for Treating Lung Cancer
  • Application of Antimicrobial Peptides in Preparation of Drugs for Treating Lung Cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1: cec4 inhibits the accumulation of exosomes in the culture supernatant of NCI-A549 cells in a dose-dependent manner

[0025] The inventors used a series of cecropins derived from blood-sucking insects as candidate molecules, including cecropin-TY1 derived from Yaofly (Parasites&Vectors, 2015), SibaCec derived from Banna gnats (Parasites&Vectors, 2015), and cecropins derived from Aedes aegypti. AeaeCec1, AeaeCec2, AeaeCec3, AeaeCec4 and AeaeCec4 (Parasites&Vectors, 2018), these antibacterial peptide cecropins are renumbered as cec1 to cec7, and the amino acid sequences of cec1 to cec7 are shown in sequence as SEQ ID No.1-SEQ ID No.7, above The polypeptides are all synthesized by chemical method, in which all amino acids are L-type, and the carbon ends of the amino acids from cec2 to cec7 are amidated. The effect of cec1 to cec7 on the release of exosomes from non-small cell lung cancer cells NCI-A549 was detected by Western blot.

[0026] Multiple groups of ex...

Embodiment 2

[0030] Example 2: cec4 does not inhibit the proliferation of NCI-A549 cells in the concentration range of 2.5-10 μg / mL

[0031] In order to clarify whether Cec4 inhibits the production of exosomes by affecting the proliferation of NCI-A549, the effect of cec4 on the proliferation of NCI-A549 was detected. Spread NCI-A549 cells in a 96-well plate (approximately 1×10 4 cells / well), after the cells adhered to the wall, a series of double-diluted cec4 was added, and an equal volume of PBS was added to the control wells. After culturing for 48 hours, CCK-8 was used to detect the effect of different concentrations of cec4 on the proliferation of NCI-A549.

[0032] The result is as figure 2 as shown ( figure 2 In ns, no significance, *p<0.05), when the concentration of cec4 is below 40μg / mL, it does not inhibit the proliferation of NCI-A549 cells. It was shown that cec4 (2.5-10 μg / mL) inhibited the production of exosomes in NCI-A549 cells not by inhibiting cell proliferation.

Embodiment 3

[0033] Example 3: cec4 does not induce NCI-A549 cell apoptosis in the concentration range of 2.5-10 μg / mL

[0034] In order to verify whether cec4 can induce apoptosis of NCI-A549 cells, NCI-A549 cells were plated in 24-well plates (approximately 2×10 5 cells / well), add 2.5, 5, 10 μg / mL cec4 respectively, add equal volume of PBS to the control group, culture for 48 hours, use PEAnexin V cell apoptosis detection kit (BD Pharmingen) to detect NCI-A549 cells treated differently Apoptosis.

[0035] The result is as image 3 As shown, compared with the control group (PBS, image 3 a) Compared to 2.5 μg / mL ( image 3 d), 5μg / mL ( image 3 c), 10 μg / mL ( image 3 b) cec4 did not induce apoptosis of NCI-A549 cells. It was shown that cec4 (2.5-10 μg / mL) inhibited the production of exosomes in NCI-A549 cells not by inducing apoptosis.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the application of an antimicrobial peptide (cec4) in the preparation of drugs for treating lung cancer. The amino acid sequence of the antimicrobial peptide (cec4) is shown in SEQ ID No.4, wherein all amino acids are L-type. The invention discloses a new application of the antibacterial peptide derived from blood-sucking insects, and provides a new direction for developing new drugs for treating lung cancer.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to the application of an antibacterial peptide in the preparation of drugs for treating lung cancer. Background technique [0002] Lung cancer is currently one of the most common malignant tumors around the world. According to data released by the American Cancer Society in 2019, among the top ten new cancer cases and deaths in the United States, lung cancer ranks among both male and female cancer patients in the first two places. According to the "Annual Report on Cancer Registration in China in 2019", lung cancer still ranks first in the incidence and mortality of malignant tumors in China, and its incidence and mortality have reached the level of developed countries. According to histological characteristics, lung cancer can be divided into two types: non-small cell lung cancer (NSCLC) and non-small cell lung cancer (NSCLC), which account for 80-85% of the total lung cancer patients. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/17A61P35/00
CPCA61K38/1767A61P35/00
Inventor 熊飞
Owner THE SECOND HOSPITAL AFFILIATED TO SUZHOU UNIV